Insider Trading activities at Tempest Therapeutics, Inc. (TPST)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tempest Therapeutics, Inc. (TPST) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tempest Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1544227.

Total stock buying since 2013: $31,042,515.
Total stock sales since 2013: $967,186.
Total stock option exercises since 2013: $0.


20 insiders reported insider trading activities at Tempest Therapeutics, Inc. (TPST):
Insider trading activities of Malley Thomas
Insider trading activities of Versant Side Fund Iv, L.p.
Insider trading activities of Whiting Samuel
Insider trading activities of Kozin Marc D
Insider trading activities of Dipp Michelle
Insider trading activities of Capello Jeffrey D
Insider trading activities of Young Jeffrey E
Insider trading activities of Fisher Mary
Insider trading activities of Harding David
Insider trading activities of Aldrich Richard
Insider trading activities of Mcneely Theresa
Insider trading activities of Stock Harald F.
Insider trading activities of Woiwode Thomas
Insider trading activities of Longwood Fund, L.p.
Insider trading activities of Chapman Paul W.d.
Insider trading activities of Westphal Christoph H
Insider trading activities of Brady Stephen R
Insider trading activities of Tzianabos Arthur
Insider trading activities of Bleck Christopher A
Insider trading activities of Dubensky Thomas W.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Tempest Therapeutics, Inc. (TPST).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 39,672 $83,801 787,999 $967,186 0 $0
2022 2,122,344 $5,017,727 0 $0 0 $0
2016 1,907,212 $14,641,337 0 $0 0 $0
2015 85,550 $2,528,108 0 $0 0 $0
2014 426,072 $4,252,209 0 $0 0 $0
2013 499,055 $4,519,333 0 $0 0 $0

Table 2. Monthly summary of insider trading at Tempest Therapeutics, Inc. (TPST).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-08 0 $0 787,999 $967,186 0 $0
2024-07 39,672 $83,801 0 $0 0 $0
2022-04 2,118,644 $4,999,999 0 $0 0 $0
2022-01 3,700 $17,728 0 $0 0 $0
2016-06 850,000 $5,950,000 0 $0 0 $0
2016-05 255,090 $1,910,617 0 $0 0 $0
2016-03 802,122 $6,780,720 0 $0 0 $0
2015-10 8,250 $88,706 0 $0 0 $0
2015-09 9,100 $153,388 0 $0 0 $0
2015-08 300 $5,568 0 $0 0 $0
2015-05 20,300 $163,106 0 $0 0 $0
2015-04 12,600 $367,340 0 $0 0 $0
2015-01 35,000 $1,750,000 0 $0 0 $0
2014-11 300 $7,359 0 $0 0 $0
2014-09 522 $7,423 0 $0 0 $0
2014-08 1,258 $15,002 0 $0 0 $0
2014-07 4,846 $45,296 0 $0 0 $0
2014-06 12,346 $101,568 0 $0 0 $0
2014-05 5,500 $40,443 0 $0 0 $0
2014-04 1,000 $32,229 0 $0 0 $0
2014-03 400,000 $4,000,000 0 $0 0 $0
2014-01 300 $2,889 0 $0 0 $0
2013-12 900 $8,190 0 $0 0 $0
2013-11 400 $3,460 0 $0 0 $0

Table 3. Detailed insider trading at Tempest Therapeutics, Inc. (TPST)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-08-12 Versant Side Fund Iv, L.p. Sale 387,999 1.10 427,186
2024-08-08 Versant Side Fund Iv, L.p. Sale 400,000 1.35 540,000
2024-07-03 Brady Stephen R (President and CEO) Buy 35,000 2.11 73,850
2024-07-02 Whiting Samuel (Chief Medical Officer) Buy 4,672 2.13 9,951
2022-04-29 Woiwode Thomas (Director) Buy 2,118,644 2.36 4,999,999
2022-01-07 Dubensky Thomas W. (President) Buy 2,000 4.78 9,560
2022-01-06 Whiting Samuel (Chief Medical Officer) Buy 1,700 4.80 8,168
2016-06-01 Dipp Michelle (Chief Executive Officer) Buy 425,000 7.00 2,975,000
2016-06-01 Aldrich Richard Buy 425,000 7.00 2,975,000
2016-05-18 Dipp Michelle (Chief Executive Officer) Buy 20,000 7.86 157,200
2016-05-18 Aldrich Richard Buy 20,000 7.86 157,200
2016-05-17 Dipp Michelle (Chief Executive Officer) Buy 20,000 7.56 151,200
2016-05-17 Aldrich Richard Buy 20,000 7.56 151,200
2016-05-16 Dipp Michelle (Chief Executive Officer) Buy 20,000 7.69 153,800
2016-05-13 Dipp Michelle (Chief Executive Officer) Buy 16,295 7.06 115,042
2016-05-13 Aldrich Richard Buy 16,295 7.06 115,042
2016-05-12 Dipp Michelle (Chief Executive Officer) Buy 19,800 6.92 137,115
2016-05-12 Aldrich Richard Buy 19,800 6.92 137,115
2016-05-11 Dipp Michelle (Chief Executive Officer) Buy 20,000 7.64 152,800
2016-05-11 Aldrich Richard Buy 20,000 7.64 152,800
2016-05-10 Chapman Paul W.d. (Chief Operating Officer) Buy 3,100 7.37 22,847
2016-05-10 Dipp Michelle (Chief Executive Officer) Buy 19,900 7.72 153,628
2016-05-10 Aldrich Richard Buy 19,900 7.72 153,628
2016-03-24 Dipp Michelle (Chief Executive Officer) Buy 30,000 9.23 276,900
2016-03-24 Aldrich Richard Buy 30,000 9.23 276,900
2016-03-23 Dipp Michelle (Chief Executive Officer) Buy 29,800 9.88 294,453
2016-03-23 Aldrich Richard Buy 29,800 9.88 294,453
2016-03-22 Dipp Michelle (Chief Executive Officer) Buy 29,800 10.53 313,913
2016-03-22 Aldrich Richard Buy 29,800 10.53 313,913
2016-03-21 Dipp Michelle (Chief Executive Officer) Buy 30,000 10.11 303,360
2016-03-21 Aldrich Richard Buy 30,000 10.11 303,360
2016-03-18 Dipp Michelle (Chief Executive Officer) Buy 29,900 8.72 260,757
2016-03-18 Aldrich Richard Buy 29,900 8.72 260,757
2016-03-17 Dipp Michelle (Chief Executive Officer) Buy 29,800 7.79 232,231
2016-03-17 Aldrich Richard Buy 29,800 7.79 232,231
2016-03-16 Dipp Michelle (Chief Executive Officer) Buy 29,529 7.86 232,038
2016-03-16 Aldrich Richard Buy 29,529 7.86 232,038
2016-03-15 Dipp Michelle (Chief Executive Officer) Buy 29,500 8.12 239,628
2016-03-15 Aldrich Richard Buy 29,500 8.12 239,628
2016-03-14 Dipp Michelle (Chief Executive Officer) Buy 30,000 8.05 241,590
2016-03-14 Aldrich Richard Buy 30,000 8.05 241,590
2016-03-11 Dipp Michelle (Chief Executive Officer) Buy 132,732 7.50 995,490
2016-03-11 Aldrich Richard Buy 132,732 7.50 995,490
2015-10-05 Young Jeffrey E (Chief Financial Officer) Buy 3,450 10.70 36,915
2015-10-05 Kozin Marc D Buy 4,800 10.79 51,791
2015-09-09 Fisher Mary Buy 6,100 16.49 100,588
2015-09-08 Kozin Marc D Buy 3,000 17.60 52,800
2015-08-24 Dipp Michelle (Chief Executive Officer) Buy 300 18.56 5,568
2015-05-26 Dipp Michelle (Chief Executive Officer) Buy 300 31.02 9,306
2015-05-16 Aldrich Richard Buy 20,000 7.69 153,800
2015-04-09 Mcneely Theresa (EVP, Chief Comm. Officer) Buy 226 29.68 6,707
2015-04-09 Tzianabos Arthur (President and CSO) Buy 225 28.77 6,473
2015-04-08 Mcneely Theresa (EVP, Chief Comm. Officer) Buy 174 28.79 5,009
2015-04-08 Tzianabos Arthur (President and CSO) Buy 175 28.04 4,907
2015-04-08 Malley Thomas Buy 5,000 28.50 142,500
2015-04-08 Young Jeffrey E (Chief Financial Officer) Buy 300 29.93 8,979
2015-04-08 Kozin Marc D Buy 3,000 28.45 85,350
2015-04-08 Aldrich Richard Buy 2,500 29.97 74,925
2015-04-02 Dipp Michelle (Chief Executive Officer) Buy 1,000 32.49 32,490
2015-01-13 Malley Thomas Buy 35,000 50.00 1,750,000
2014-11-24 Dipp Michelle (President and CEO) Buy 300 24.53 7,359
2014-09-23 Stock Harald F. (Director) Buy 522 14.22 7,423
2014-08-26 Stock Harald F. (Director) Buy 580 12.99 7,534
2014-08-12 Stock Harald F. (Director) Buy 678 11.02 7,468
2014-07-29 Stock Harald F. (Director) Buy 830 8.98 7,453
2014-07-28 Dipp Michelle (President and CEO) Buy 450 9.00 4,050
2014-07-15 Stock Harald F. (Director) Buy 760 9.65 7,334
2014-07-07 Aldrich Richard (Director) Buy 2,000 9.49 18,980
2014-07-01 Stock Harald F. (Director) Buy 806 9.28 7,479
2014-06-30 Aldrich Richard (Director) Buy 2,000 9.16 18,320
2014-06-23 Dipp Michelle (President and CEO) Buy 450 8.68 3,906
2014-06-23 Aldrich Richard (Director) Buy 2,000 8.81 17,628
2014-06-17 Stock Harald F. (Director) Buy 833 8.96 7,463
2014-06-16 Aldrich Richard (Director) Buy 2,000 8.52 17,040
2014-06-09 Aldrich Richard (Director) Buy 2,000 7.59 15,180
2014-06-03 Stock Harald F. (Director) Buy 1,063 7.01 7,451
2014-06-02 Aldrich Richard (Director) Buy 2,000 7.29 14,580
2014-05-27 Aldrich Richard (Director) Buy 2,000 7.50 15,000
2014-05-20 Stock Harald F. (Director) Buy 1,050 7.13 7,485
2014-05-19 Dipp Michelle (President and Chief Executive) Buy 450 7.33 3,298
2014-05-19 Aldrich Richard (Director) Buy 2,000 7.33 14,660
2014-04-10 Harding David (Chief Commercial Officer) Buy 1,000 32.23 32,229
2014-03-07 Dipp Michelle (President & CEO) Buy 100,000 10.00 1,000,000
2014-03-07 Longwood Fund, L.p. (10% Owner) Buy 100,000 10.00 1,000,000
2014-03-07 Westphal Christoph H (Director) Buy 100,000 10.00 1,000,000
2014-03-07 Aldrich Richard (Director) Buy 100,000 10.00 1,000,000
2014-01-27 Dipp Michelle (President and CEO) Buy 300 9.63 2,889
2013-12-23 Dipp Michelle (President and CEO) Buy 600 9.10 5,460
2013-11-18 Dipp Michelle (President and CEO) Buy 400 8.65 3,460
2013-09-12 Tzianabos Arthur (Chief Scientific Officer) Buy 1,000 10.32 10,320
2013-09-12 Stock Harald F. (Director) Buy 4,500 10.64 47,880
2013-09-11 Westphal Christoph H (Director) Buy 4,850 10.53 51,070
2013-09-11 Bleck Christopher A (Chief Commercial Officer) Buy 2,000 11.15 22,300
2013-09-11 Aldrich Richard (Director) Buy 4,850 10.54 51,118
2013-03-18 Longwood Fund, L.p. Buy 419,444 9.00 3,774,996
2013-03-18 Malley Thomas Buy 50,000 9.00 450,000
2013-03-18 Capello Jeffrey D Buy 11,111 9.00 99,999

Insider trading activities including stock purchases, stock sales, and option exercises of TPST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tempest Therapeutics, Inc. (symbol TPST, CIK number 1544227) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.